The microRNA miR-221-3p inhibits the inflammatory response and promotes skin wound healing in diabetes by targeting DYRK1A expression, thereby regulating the DYRK1A/STAT3 signaling pathway. The gene discussed is STAT3; the disease is diabetes mellitus.